Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence GDEELLRFSN
Primary information
sequence IDSeq_2539
Peptide sequenceGDEELLRFSN
CancerPDF_ID CancerPDF_ID9544, CancerPDF_ID11456, CancerPDF_ID13327, CancerPDF_ID13804,
PMID21533267,26992070,20974924,20974924
Protein NameProtein AMBP,Protein AMBP,Protein AMBP,Protein AMBP
UniprotKB Entry NameAMBP_HUMAN,AMBP_HUMAN,AMBP_HUMAN,AMBP_HUMAN
FluidSerum,Serum,Plasma,Plasma
M/Z590.28,1178.5568,1179.565,1179.565
Charge2,NA,2,2
Mass (in Da)NA,1179.56389,NA,NA
fdrNA,NA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS,LC-MS
Peptide Identification techniqueLC/MS/MS,LC-MS/MS,LC-MS/MS,LC-MS/MS
Quantification TechniqueMultiple Reaction Monitoring,NA,NA,NA
Labelled/Label FreeLabel Free,Label Free,Label Free,Label Free
FDR1.49,FDR 1 %,NA,NA
CancerPDF_ID CancerPDF_ID9544, CancerPDF_ID11456, CancerPDF_ID13327, CancerPDF_ID13804,
p-ValueNA,NA,NA,NA
SoftwareMASCOT,SEQUEST and Maxquant,MASCOT and SEQUEST,MASCOT and SEQUEST
Length10,10,NA,NA
Cancer TypeLung adenocarcinoma,Melanoma,"Multiple myeloma patients, Acute myeloid leukemia","Multiple myeloma patients, Acute myeloid leukemia"
DatabaseSwissprot Database (57.4),SwissProt Database,Uniprot database,Uniprot database
ModificationNA,NA,NA,NA
Number of Patients62 lung adenocarcinoma and 30 healthy control,8 cancer samples and 4 healthy samples,NA,NA
Regulation"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Present in 5 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples.",NA,NA
ValidationMRM-based validation of 19 candidates,na,NA,NA
SensitivityNA,NA,NA,NA
SpecificityNA,NA,NA,NA
AccuracyNA,NA,NA,NA
Peptide AtlasNA
IEDB